BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8484809)

  • 1. New procedure for analysing drug binding data, exemplified by warfarin binding to human serum albumin.
    Vorum H; Bang D; Fisker K
    Biochem Pharmacol; 1993 Apr; 45(8):1715-20. PubMed ID: 8484809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitate and stearate binding to human serum albumin. Determination of relative binding constants.
    Vorum H; Fisker K; Honoré B
    J Pept Res; 1997 Apr; 49(4):347-54. PubMed ID: 9176819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data plotting of warfarin binding to human serum albumin.
    Pablo Villamor J; Zatón AM
    J Biochem Biophys Methods; 2001 Mar; 48(1):33-41. PubMed ID: 11282400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity binding of two molecules of warfarin and phenprocoumon to human serum albumin.
    Vorum H; Fisker K; Brodersen R
    Biochim Biophys Acta; 1994 Apr; 1205(2):178-82. PubMed ID: 8155695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid method for the estimation of drug-albumin affinity constants in human plasma.
    Solomon HM; Thomas GB
    Clin Pharmacol Ther; 1971; 12(3):445-8. PubMed ID: 5567799
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum albumin binding of palmitate and stearate. Multiple binding theory for insoluble ligands.
    Brodersen R; Vorum H; Skriver E; Pedersen AO
    Eur J Biochem; 1989 Jun; 182(1):19-25. PubMed ID: 2731550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of benzopyranes to human serum albumin. A structure-affinity study.
    Ferrer JM; Leiton MJ; Zatón AM
    J Protein Chem; 1998 Feb; 17(2):115-9. PubMed ID: 9535273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of warfarin with human serum albumin. A stoichiometric description.
    Larsen FG; Larsen CG; Jakobsen P; Brodersen R
    Mol Pharmacol; 1985 Feb; 27(2):263-70. PubMed ID: 3969070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
    Tillement JP; Zini R; d' Athis P; Vassent G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):307-13. PubMed ID: 4850753
    [No Abstract]   [Full Text] [Related]  

  • 11. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry.
    Dröge JH; Janssen LH; Wilting J
    Biochim Biophys Acta; 1985 Mar; 827(3):396-402. PubMed ID: 3970944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of the effects of ethanol on warfarin binding to human serum albumin.
    Ha CE; Petersen CE; Park DS; Harohalli K; Bhagavan NV
    J Biomed Sci; 2000; 7(2):114-21. PubMed ID: 10754385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.
    Rich RL; Day YS; Morton TA; Myszka DG
    Anal Biochem; 2001 Sep; 296(2):197-207. PubMed ID: 11554715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening.
    Parikh HH; McElwain K; Balasubramanian V; Leung W; Wong D; Morris ME; Ramanathan M
    Pharm Res; 2000 May; 17(5):632-7. PubMed ID: 10888318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments.
    Bos OJ; Remijn JP; Fischer MJ; Wilting J; Janssen LH
    Biochem Pharmacol; 1988 Oct; 37(20):3905-9. PubMed ID: 3190737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristic acid binding to human serum albumin investigated by dialytic exchange rate.
    Pedersen AO; Brodersen R
    J Biol Chem; 1988 Jul; 263(21):10236-9. PubMed ID: 3392011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple cobinding of two ligands to serum albumin: a stoichiometric description of binding equilibria.
    Larsen CG; Larsen FG; Jakobsen P; Brodersen R
    Arch Biochem Biophys; 1985 May; 239(1):74-86. PubMed ID: 4004264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 20. An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone.
    Aarons LJ; Schary WL; Rowland M
    J Pharm Pharmacol; 1979 May; 31(5):322-30. PubMed ID: 37303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.